Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C43H53NO14.3H2O |
Molecular Weight | 861.9251 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 11 / 11 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C5=CC=CC=C5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6
InChI
InChIKey=XCDIRYDKECHIPE-QHEQPUDQSA-N
InChI=1S/C43H53NO14.3H2O/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45;;;/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52);3*1H2/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+;;;/m0.../s1
Molecular Formula | H2O |
Molecular Weight | 18.0153 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C43H53NO14 |
Molecular Weight | 807.8792 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 11 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:26:50 UTC 2023
by
admin
on
Fri Dec 15 15:26:50 UTC 2023
|
Record UNII |
15H5577CQD
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C67437
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DOCEFREZ(WITHDRAWN: BREAST, PROSTETIC, HEAD AND NECK NEOPLASMS, CARCINOMA,NON-SMALL-CELL-LUNG, ADENOCARCINOMA)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DOCETAXEL TEVA (AUTHORIZED: BREAST, PROSTETIC, HEAD AND NECK NEOPLASMS, CARCINOMA,NON-SMALL-CELL-LUNG, ADENOCARCINOMA)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DOCETAXEL KABI (AUTHORIZED: BREAST, PROSTETIC, HEAD AND NECK NEOPLASMS, CARCINOMA,NON-SMALL-CELL-LUNG, ADENOCARCINOMA)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TAXESPIRA (AUTHORISED: CARCINOMA, NON-SMALL-CELL LUNG)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
LIVERTOX |
NBK548899
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
NDF-RT |
N0000175592
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
WHO-VATC |
QL01CD02
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TAXOTERE (AUTHORIZED: STOMACH NEOPLASMS)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DOCETAXEL WINTHROP (AUTHORIZED: BREAST, PROSTETIC, HEAD AND NECK NEOPLASMS, CARCINOMA,NON-SMALL-CELL-LUNG, ADENOCARCINOMA)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DOCETAXEL MYLAN (AUTHORIZED: BREAST, PROSTETIC, HEAD AND NECK NEOPLASMS, CARCINOMA,NON-SMALL-CELL-LUNG, ADENOCARCINOMA)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DOCETAXEL TEVA PHARMA(AUTHORIZED: CARCINOMA, NON-SMALL-CELL LUNG)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DOCETAXEL ACCORD (AUTHORIZED: BREAST, PROSTETIC, HEAD AND NECK NEOPLASMS, CARCINOMA,NON-SMALL-CELL-LUNG, ADENOCARCINOMA)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TAXOTERE (AUTHORIZED: BREAST, PROSTETIC, STOMACH, HEAD AND NECK NEOPLASMS, CARCINOMA,NON-SMALL-CELL-LUNG, ADENOCARCINOMA)
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
WHO-ATC |
L01CD02
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
FDA ORPHAN DRUG |
649918
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
||
|
NCI_THESAURUS |
C1490
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4672
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
SUB25446
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
C067311
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
FF-68
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
DTXSID80872444
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
m4712
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | Merck Index | ||
|
DOCETAXEL
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
148123
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
1224551
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
CHEMBL92
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
72962
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | RxNorm | ||
|
Docetaxel
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
6809
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
59809
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
100000089469
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
C1526
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
939
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
15H5577CQD
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
148408-66-6
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
DB01248
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY | |||
|
15H5577CQD
Created by
admin on Fri Dec 15 15:26:50 UTC 2023 , Edited by admin on Fri Dec 15 15:26:50 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
ANHYDROUS->SOLVATE | |||
|
TRANSPORTER -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||